Envoy Medical, Inc. (COCH) Stock Analysis

Company Overview

The market values Envoy Medical, Inc. (COCH) at $54.81M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 43 employees.

The 52-week range on file runs from $0.36 to $1.89. COCH last closed at $0.71 on September 4, 2026. That is −$0.02 (−2.74%) against the previous close. The latest close sits 95.59% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $241.00K. Against the prior fiscal year total of $225.00K, that is a change of +7.11%. The same year closed with a net loss of $23.76M. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −0.74.

Across the 4 fiscal years on file, revenue moves from $237.00K in 2022 to $241.00K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 264.77 times revenue. On price-to-sales that is 89 times the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −47.41%. Across 5 years the annualized return works out at −40.72%. Beta against the wider market is reported at 1.9. Annualized volatility over the trailing 5 years is 136.13%.

Growth & Income

The record shows no dividend for COCH.

The strongest complete calendar year on file is 2022 at +2.87%; the weakest is 2023 at −81.93%. Of the 4 complete calendar years on file, 1 finished higher. So far in 2026 the price is +7.41%.